Press release content from Business Wire. The AP news staff was not involved in its creation.
Emerson Invests in Fluxa
ST. LOUIS--(BUSINESS WIRE)--Feb 25, 2021--
Emerson (NYSE: EMR), a technology and industrial software company, today announced it has made an equity investment in Fluxa, whose Process & Knowledge Management (PKM ™ ) software seamlessly manages product and process specifications throughout the drug development lifecycle. The investment will build on Emerson’s leading life sciences capabilities and help Fluxa expand its technology development and commercial pipeline to deliver solutions to the market.
The emergence of COVID-19 has sparked innovation in the life sciences manufacturing development process, as a cycle that previously required over eight years was completed in less than 18 months through expedited research and development and automation technologies, including those offered by Emerson. This acceleration and its possibilities for the industry have made technology transfer – critical to move quickly from R&D to production – a main priority for life sciences companies.